GLOBUS MEDICAL, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
GLOBUS MEDICAL, INC. (GMED) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of -$7.20 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-11-06
- GLOBUS MEDICAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2025-09-30 was -$7.20M.
- GLOBUS MEDICAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2025-06-30 was -$34.80M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month |
|---|---|---|---|
| 2025-09-30 | -$7.20M 10-Q · filed 2025-11-06 | -$42.00M derived: sum of 2 quarters · filed 2025-11-06 | -$34.80M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$34.80M 10-Q · filed 2025-08-07 | -$34.80M 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |